Subscribe and receive the latest updates on trends, data, events and more.
Join 57,000+ members of the natural products community.
July 30, 2014
A new study published in the July issue of the Journal of Bone and Mineral Research, a peer-reviewed scientific journal, found no increased risk of coronary heart disease (CHD) or all-cause mortality in post-menopausal women supplementing with calcium and vitamin D. The study, “ The Effects of Calcium Supplementation on Verified Coronary Heart Disease Hospitalization and Death in Postmenopausal Women: A Collaborative Meta-Analysis of Randomized Controlled Trials,” is the fifth study in the last couple of years to reaffirm calcium’s safety, which is consistent with the overall body of scientific research.
“The evidence for why women should have confidence in the safety of calcium continues to grow,” said Andrea Wong, Ph.D., vice president of scientific and regulatory affairs at the Council for Responsible Nutrition (CRN). “The benefits of calcium occur at every life stage, but because of the natural loss of calcium that occurs as we age, getting enough of this essential nutrient is especially important for the older populations, who are at risk for falls and fractures. Post-menopausal women can confidently take calcium supplements if getting enough calcium from the diet is not possible.”
“While food-derived calcium is the optimal source to achieve the recommended daily intake (RDI) of calcium, in cases where this RDI cannot be reached from food sources alone the use of long-term calcium supplementation with vitamin D in older women should be considered,” the study authors reported.
The Council for Responsible Nutrition (CRN), a Washington, D.C.-based national trade association for the dietary supplement industry, is a monthly contributor to the NewHope360.com blog. CRN’s thought-provoking commentary looks at issues impacting the dietary supplement industry and offers perspectives for addressing these issues.
Steve Mister Esq., President and CEO
Judy Blatman, Senior Vice President of Communications
John Hathcock, Ph.D., Senior Vice President of Scientific and International Affairs
Douglas “Duffy” MacKay, N.D., Vice President of Scientific and Regulatory Affairs
Mike Greene, Vice President of Government Relations
You May Also Like
NCN report analyzes investment slowdown, explores opportunitiesMar 2, 2024
Free AF launches AF Sparkling Rosé with Afterglow™ – press releaseMar 1, 2024
Top Trends at Expo West 2024 – slideshowMar 1, 2024
Natural Products Expo West offers investors a wealth of eventsMar 1, 2024